Device Week – April 25, 2016
This article was originally published in The Gray Sheet
Executive Summary
On this week's podcast, The Gray Sheet team talks about renewed TAVR patent battles, hearing aid regulations, the most frequent citation in FDA QSR device warning letters, actions in Congress, Califf's priorities, criticisms of FDA's approach to cybersecurity and an FDA orthopedics panel vote.